Tight development timelines and accelerated approval pathways favor simple, cost-effective capsule formulations. Capsules are a common oral solid dosage form and are produced in a variety of shapes, ...

Advancements in soft capsule technology can enable the development of soft capsule formulations, which are becoming the preferred method of oral administration. Soft capsule formulation technology ...

Nano-capsules that can modulate the release of the incorporated substances may have applications in the formulation of functional foods, as well as relevance in food preservation and storage, ...

Cyclosporine has revolutionised the transplantation scene in the last 20 years by helping with immunosuppresion. Novartis have so far had the patent Cyclosporine has revolutionised the transplantation ...

Fagron, the leading global player in pharmaceutical compounding, launches DiluCap, a new line of six excipients for compounding pharmacies allowing for easier and faster capsule formulation. Choosing ...

Introduction: Different oral sustained-release (SR) formulations of tramadol have been introduced in pain treatment in order to prolong the dosage interval to improve convenience for the patient. The ...

Phase I study of imetelstat (GRN163L) in combination with paclitaxel (P) and bevacizumab (B) in patients (pts) with locally recurrent or metastatic breast cancer (MBC). Methods: In this randomized, ...

IIIM functions under the Council of Scientific and Industrial Research (CSIR). The Indian Institute of Integrative Medicine (IIIM) here on Wednesday said it has developed a capsule formulation from ...

LincNutri today announced the launch of its NAD+ Supplement for Women, a multi-ingredient daily formula designed to support cellular energy, antioxidant defense, and healthy aging routines. Each ...

Is there any benefit to using venlafaxine extended-release, 75 mg twice daily, vs venlafaxine extended-release, 150 mg once daily? Would the drug level, once at steady state, be higher given the daily ...

The Company has not disclosed a reason for the medication discontinuation, however in 2017, the FDA reported that olaparib capsules were being phased out of the US market. [UPDATE 9/6/18] Lynparza ...